These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23222216)

  • 1. Absorption of higher-molecular-weight substances via the lung.
    von Wichert P
    Pol Arch Med Wewn; 2012; 122 Suppl 1():78-83. PubMed ID: 23222216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lung, an organ for absorption?
    von Wichert P; Seifart C
    Respiration; 2005; 72(5):552-8. PubMed ID: 16210898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogels for controlled pulmonary delivery.
    Du J; Du P; Smyth HD
    Ther Deliv; 2013 Oct; 4(10):1293-305. PubMed ID: 24116913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs.
    Tronde A; Nordén B; Marchner H; Wendel AK; Lennernäs H; Bengtsson UH
    J Pharm Sci; 2003 Jun; 92(6):1216-33. PubMed ID: 12761811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation.
    Rabinowitz JD; Lloyd PM; Munzar P; Myers DJ; Cross S; Damani R; Quintana R; Spyker DA; Soni P; Cassella JV
    J Pharm Sci; 2006 Nov; 95(11):2438-51. PubMed ID: 16886198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of increased nanoparticle absorption by infant lungs: future prospects.
    Garcia-Contreras L; Ibrahim M
    Ther Deliv; 2013 Apr; 4(4):417-20. PubMed ID: 23557280
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.
    Nahar K; Gupta N; Gauvin R; Absar S; Patel B; Gupta V; Khademhosseini A; Ahsan F
    Eur J Pharm Sci; 2013 Aug; 49(5):805-18. PubMed ID: 23797056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems and chances of the application of systemically acting drugs via the lung].
    von Wichert G; von Wichert P
    Med Klin (Munich); 2006 Sep; 101(9):718-23. PubMed ID: 16977396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaling medicines: delivering drugs to the body through the lungs.
    Patton JS; Byron PR
    Nat Rev Drug Discov; 2007 Jan; 6(1):67-74. PubMed ID: 17195033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of models for the evaluation of pulmonary drug disposition.
    Liu X; Jin L; Upham JW; Roberts MS
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):487-505. PubMed ID: 23294005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalation Biopharmaceutics: Progress Towards Comprehending the Fate of Inhaled Medicines.
    Ehrhardt C
    Pharm Res; 2017 Dec; 34(12):2451-2453. PubMed ID: 29147818
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical perspectives on pulmonary systemic and macromolecular delivery.
    Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
    Sakagami M
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The particle has landed--characterizing the fate of inhaled pharmaceuticals.
    Patton JS; Brain JD; Davies LA; Fiegel J; Gumbleton M; Kim KJ; Sakagami M; Vanbever R; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S71-87. PubMed ID: 21133802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lungs as a portal of entry for systemic drug delivery.
    Patton JS; Fishburn CS; Weers JG
    Proc Am Thorac Soc; 2004; 1(4):338-44. PubMed ID: 16113455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can we bring high drug doses to the lung?
    Claus S; Weiler C; Schiewe J; Friess W
    Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary drug delivery: medicines for inhalation.
    Henning A; Hein S; Schneider M; Bur M; Lehr CM
    Handb Exp Pharmacol; 2010; (197):171-92. PubMed ID: 20217530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of non-spherical particles in bifurcating airways.
    Bunchatheeravate P; Curtis JS
    Pharm Dev Technol; 2014 Dec; 19(8):942-51. PubMed ID: 24320756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches towards enhanced transepithelial drug delivery.
    Majumdar S; Mitra AK
    Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.